Willamette Valley Cancer Institute — Springfield, Oregon

Willamette Valley Cancer Institute is a clinical research site located in Springfield, Oregon, United States 97477.

Crixeo Clinical Trials Trust Score: 12/100 (FAILING). This profile has not yet been claimed by the site owner.

Willamette Valley Cancer Institute has participated in 4 clinical trials.

Therapeutic areas: Platinum Resistant Ovarian Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma.

Sponsors: Mateon Therapeutics, Revolution Medicines, Inc., Celgene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Springfield

Browse all research sites in Oregon · View every site in Springfield

Sponsor Feasibility Report

Trust Score: 12/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Willamette Valley Cancer Institute?

Willamette Valley Cancer Institute has a Crixeo Trust Score of 12/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Willamette Valley Cancer Institute conducted?

Willamette Valley Cancer Institute has 4 clinical trials on record. Their work covers Platinum Resistant Ovarian Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma.

Is Willamette Valley Cancer Institute accredited by Crixeo Clinical Trials?

Willamette Valley Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Willamette Valley Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.